Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,501Revenue (TTM) $M1,149Net Margin (%)-9.5Altman Z-Score2.5
Enterprise Value $M2,548EPS (TTM) $-0.2Operating Margin %-15.4Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-14.6Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-226.4ROA % (ttm)-3.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-5.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M559ROIC % (ttm)-4.7Gross Margin Increase y-yN

Gurus Latest Trades with OPK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

OPK is held by these investors:



OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-09-19Buy15,000$6.01-23.63view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-09-18Buy40,000$6-23.5view
Logal AdamSr. Vice President, CFO 2017-09-15Buy1,500$6.03-23.88view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-09-15Buy80,000$6.01-23.63view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-09-14Buy260,000$5.98-23.24view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-08-25Buy25,000$6.17-25.61view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-08-24Buy10,000$6.24-26.44view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-08-23Buy12,000$6.13-25.12view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-08-22Buy1,800$6.13-25.12view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2017-08-21Buy25,000$6.1-24.75view

Press Releases about OPK :

Quarterly/Annual Reports about OPK:

News about OPK:

Articles On GuruFocus.com
OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center Jan 12 2018 
OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center Jan 12 2018 
OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertroph Nov 27 2017 
OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertroph Nov 27 2017 
Report: Developing Opportunities within PayPal, Exelixis, International Business Machines, Opko Heal Nov 27 2017 
OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Cl Nov 07 2017 
OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017 Nov 03 2017 
OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Oct 26 2017 
OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE Oct 12 2017 
Weekly CEO Buys Highlights Sep 25 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK